The European Medicines Agency has recommended the first emergency treatment for allergic reactions to be administered as a nasal spray, not as an injection.
Eurneffy (epinephrine) should be granted a marketing authorization for anaphylaxis and idiopathic or exercise induced anaphylaxis, the…
[ad_2]
Source link
